SRR1387809
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1356619 | GTEX | — | 0.954 |
| 2 | SRR807591 | GTEX | — | 0.951 |
| 3 | SRR1420984 | GTEX | — | 0.951 |
| 4 | SRR1415895 | GTEX | — | 0.938 |
| 5 | SRR1447693 | GTEX | — | 0.934 |
| 6 | SRR1082262 | GTEX | — | 0.927 |
| 7 | SRR1444580 | GTEX | — | 0.921 |
| 8 | SRR1474777 | GTEX | — | 0.920 |
| 9 | SRR1464373 | GTEX | — | 0.918 |
| 10 | SRR1468514 | GTEX | — | 0.917 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 16 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| OXIDATIVE_PHOSPHORYLATION | 0.424 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.315 | Cobimetinib | — uncovered |
| FATTY_ACID_METABOLISM | 0.258 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.244 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.226 | Remibrutinib | — uncovered |
| MYOGENESIS | 0.213 | Inavolisib | — uncovered |
| PEROXISOME | 0.190 | Idelalisib | — uncovered |
| SPERMATOGENESIS | 0.177 | Inavolisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.171 | Inavolisib | — uncovered |
| HEME_METABOLISM | 0.141 | Temsirolimus | — uncovered |
| UV_RESPONSE_DN | 0.140 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.126 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.111 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.037 | Remibrutinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.024 | Inavolisib | — uncovered |
| APICAL_SURFACE | 0.009 | Temsirolimus | — uncovered |